You are here: Industry Insights > Lung

News List

Metastatic NSCLC therapy, tepotinib, given Breakthrough Designation europeanpharmaceuticalreview
September 12, 2019
Tepotinib, an investigational therapy for patients with metastatic non-small cell lung cancer has been given Breakthrough Therapy Designation.
First treatment for patients with rare lung disease approved europeanpharmaceuticalreview
September 10, 2019
The FDA has approved the first treatment for interstitial lung disease associated with systemic sclerosis or scleroderma.
Vitamin E Oil Might Be Cause of Vaping-Linked Lung Injuries drugs
September 09, 2019
Lab tests have found a chemical derived from vitamin E in samples of vaping products that have sickened people in 25 states.
Underused Drug Combo May Up Survival in Lung Transplant drugs
September 06, 2019
A little used immunosuppression regimen may substantially improve survival following lung transplant, according to a study published online in JAMA Network Open.
Health Officials Close in on Culprit in Vaping Lung Injury Cases drugs
September 06, 2019
Lab tests have found a chemical derived from vitamin E in samples of vaping products that have sickened people in 25 states.
Tagrisso approved in China as a 1st-line treatment for EGFR-mutated non-small cell lung cancer worldpharmanews
September 05, 2019
AstraZeneca announced that it has received marketing authorisation from China's National Medical Products Administration (NMPA) for Tagrisso (osimertinib) as a 1st-line treatment for adults with locally-advanced...
Second Possible Death Reported in U.S. From Vaping-Related Lung Illness drugs
September 05, 2019
A second death in the United States from severe respiratory illness possibly associated with vaping is being investigated by health officials.
Mylan generic of lung cancer drug Alimta approved europeanpharmaceuticalreview
September 04, 2019
Mylan NV’s generic version Eli Lilly and Co’s lung cancer drug, Alimta, has been given tentative approval by the FDA.
Rova-T programme discontinued following poor trial results europeanpharmaceuticalreview
September 03, 2019
A Phase III trial evaluating Rova-T as a first-line maintenance therapy for advanced small-cell lung cancer demonstrated no survival benefit.
As Lung Injury Cases Rise, CDC Advises 'Do Not Vape' drugs
September 02, 2019
The number of people who have developed a severe form of lung disease potentially tied to vaping has now risen to 215 cases across 25 states...

Previous page 1 2 3 4 5 6 7 8 9 Next page